UMS AG reports on the liquidation period from May 1 to August 31, 2018 (final liquidation financial statements)

Hamburg, October 12, 2018. UMS United Medical Systems International AG i. L. (UMS, ISIN DE 0005493654 / WKN 549365) has reported on the liquidation period from May 1, 2018 to August 31, 2018 (final liquidation financial statements).

The Company's final legal dispute was settled in that liquidation period, as the Company entered into a settlement agreement with the opposing party. This provided the Company with a settlement amount of EUR 355k, with the earnings per share amounting to EUR 7 cents per share. The bank balances amounted to EUR 2,733k or 63 cents per share, up from EUR 2,704k at the beginning of the liquidation period. Equity increased to EUR 2,639k or 62 cents per share, from EUR 2,343k or 55 cents per share at the beginning of the liquidation period.

The full report is available on the Company's website at

The Company in Brief

UMS International AG is a stock corporation listed in the Prime Standard of Deutsche Börse AG. On August 14,2014, the Company sold its interest in United Medical Systems (DE), Inc. and thus sold its entire assets. The Company's Extraordinary General Meeting on September 25, 2014 approved the transfer of assets and liabilities. The agreement was finalized on November 11, 2014. Upon completion of the transfer of assets, the company's corporate purpose was changed to the management of its own assets.

At their annual meeting on April 27, 2015, the shareholders resolved to dissolve the company on April 30, 2015.

Contact

Christian Möller, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-Mail: